The Global Biotech & Pharma Patent (China) Summit 2026 will bring together leading pharmaceutical companies, biotech firms, research institutions, law firms, intellectual property agencies, and industry experts from around the world. Centered on the core theme of "Focus on APAC Global Vision,Guided by Insight, Innovation Without Borders," and the summit will delve into patent strategies for cutting-edge technologies, global patent deployment and management, cross-border licensing and collaboration, as well as the latest trends in policies and ethics.We are in an era of global health revolution driven by biotechnological innovation. From gene editing to AI-driven drug discovery, disruptive technologies are redefining pharmaceutical R&D. In this process, intellectual property—particularly patents—serves not only as a legal shield but also as a core strategic asset determining the value of technology transfer and global collaboration.China has emerged as an indispensable presence in this landscape. With substantial R&D investment and a maturing ecosystem, it has transitioned from a "fast follower" to a "parallel leader," contributing original achievements across multiple fields while deepening global collaboration.However, the global patent landscape is increasingly complex, with regional differences in examination, cross-border enforcement challenges, and new models like open-source licensing. These demand more sophisticated IP strategies. Key questions now are: How to build a patent system combining international vision with local expertise? How to accelerate innovation through strategic IP management? The answers will determine the biopharmaceutical industry's success in the coming decade. These points are precisely part of the original intent behind hosting this summit and part of the key topics to be discussed with relevant professionals. Join us on Jun 4th-5th! Register now to reserve your place at this exclusive event. Agenda Overview: Day 1 Morning:The integration and challenges of regulatory science and the patent systemü Latest Practices and Future Prospects of Drug Data Protection and Market Exclusivity Systemsü How to Optimize Application Strategies and Quality Management of Biopharmaceutical Patents under the Fast-Track Patent Examination Systemü Patent Challenges in the ADC/Bispecific Antibody 2.0 Eraü A New Balance Under Global Competition and Cooperation: Challenges, Evolution, and Multinational Corporate Strategies of Biopharmaceutical Patent Linkage SystemsDay 1 Afternoon:Maximizing Patent Value and New Commercialization Modelsü Biosimilar Patent Challenge Strategies and Patent Cliff Managementü Patent Due Diligence and Investment Risksü Trade Secrets vs. Patent Trademarks: Biopharmaceutical Innovation Protection Strategies in High-Risk Litigationü Maximizing Innovation Value Using a Composite Intellectual Property Strategy (Patent + Data Protection)ü Intellectual Property Risks and Management in the Context of Supply Chain Restructuring and Digital Therapy ComplianceDay 2 Morning:Global Perspective on Biopharmaceutical R&D and Patent Strategies and Competitionü How to Develop Differentiated Claim Strategies to Cope with Strict Inventiveness/Obviousness Examinations in Various Countriesü Patent Issues and Intellectual Property Risk Prevention in Cross-Border Biopharmaceutical Collaborationü Patent Layout and Cross-Border Expansion Strategies for Pharmaceutical Companiesü Patent Issues in Cross-Border Biopharmaceutical Collaboration and Strategies for Protecting Pharmaceutical Intellectual PropertyDay 2 Afternoon:Opportunities and Legal Challenges of AI in Biotechnology and Pharmaceutical Intellectual Propertyü Patent Challenges and Strategies for AI-Driven Drug Discovery, Gene Editing, and Cell and Gene Therapyü Patent Eligibility and Data Protection in AI-Driven Drug Developmentü Balance and Development of Innovative and Generic Drugs under the Drug Patent Linkage Systemü Deep Integration of AI in Drug Development and Intellectual Property Protection Strategies More details about the topics, please find attached agenda. Partial inviting Companies & Institutions : CNIPAEUIPOWIPOPhIRDAEli Lilly and CompanyNovo NordiskJohnson & JohnsonAbbVieMerck Sharp & DohmeRocheAstraZenecaNovartisPfizerAmgenSanofiGileadSciencesBristol-Myers SquibbVertex PharmaceuticalsRegeneron PharmaceuticalsNovo NordiskChugai PharmaceuticalGSKMerck KGaASun PharmaceuticalCVS HealthDaiichi SankyōLONZATakeda PharmaceuticalHengrui PharmaceuticalsUCBArgenxAlnylam Pharmaceuticals IncCelltrionOtsuka HoldingsGalderma GroupTEVAWuXi AppTecWest PharmaceuticalBeiGeneBiogen IncLabCorpBayerDivis LaboratoriesSandozICONAstellas PharmaModernaBaxterNeurocrine BiosciencesCipla Ltd.,ViatrisHansoh PharmDr. Reddy'sLupin LimitedServierIncyte, CorpGenmabEisaiLuoxin Pharmaceutical GroupCSPC PharmaTide PharmaceuticalBRILLIANT PHARMACEUTICALInnovent BiologicsBio-Thera SolutionsSalubris PharmaceuticalsHaiscom pharmaceuticalEaston BiopharmaceuticalsHua MedicineGenscript CorporationTransThera BiosciencesCHIPSCREEN BIOSCIENCESHumanwell PharmaceuticalFosun Kite BiotechnologyHybio PharmaceuticalAllist PharmaceuticalsXiangxue Life SciencesHumanwell HealthcareXuanZhu PharmaStaidsonShineway PharmaceuticalKanghong PharmaceuticalI-Mab BiopharmaCRDCNew Era PharmaceuticalAscentage PharmaARSUAMOONJiangxi Jemincare GroupYangzijiang PharmaceuticalLintonPharm Co., Ltd.Grand PharmaceuticalQilu PharmaceuticalShanghai PharmaceuticalsKelun PharmaceuticalBuchang PharmaceuticalsLivzon PharmaceuticalSunshineLakeHuahai PharmaceuticalConba Pharmaceutical3SBio Inc.Jiuzhou PharmaceuticalHisun PharmaceuticalSimcere PharmaceuticalBeijing Intellectual Property CourtShanghai Technology ExchangeNhwa Pharmaceutical Tongyuankang PharmaceuticalKangma BiotechnologyRege BiotechZhejiang BaiChengPharmaceuticalTongji UniversityHitGen Inc.Impact TherapeuticsHutchison China MediTechCR Double CraneSinocelltech Gendicine BiopharmaceuticalShenyang Xingqi PharmaceuticalImpact TherapeuticsAsieris PharmaceuticalsMetseraLaNova MedicinesInnolake BiopharmChengdu Guowei BiologicalRibo Life Science Johnson & Johnson MedTechAdlai NortyeKejun PharmaceuticalBeijing Wuhe Boao PharmaceuticalYoujia (Hangzhou) BiotechnologyLyvgen BiopharmaMabwell (Shanghai) BioscienceIASO BioTOT BiopharmSuzhou Gelanke PharmaceuticalBioNTechSanegeneBioMedical Academy of Sciences & ResearchKangbaida (Sichuan) BiologicalShanghai Luoqi BiotechnologyYuekang Kechuang PharmaceuticalSunshineLakeKelun-Bota BiotechChina Biologic ProductsJunhemeng BiotechXiamen Amoytop BiotechYuansong BiotechnologyWuXi BiologicsJ Xinnian PharmaceuticalShanghai Yunsheng Yanxin BiotechSimcere Pharmaceuticalwebsite://en.zvuaz.cn/p/1176775/
引(yin)(yin)言隨著汽(qi)(qi)(qi)車(che)(che)(che)(che)產業(ye)(ye)(ye)向(xiang)“新(xin)(xin)(xin)(xin)(xin)(xin)四化(hua)(hua)”(電(dian)(dian)(dian)(dian)動(dong)(dong)(dong)化(hua)(hua)、智(zhi)(zhi)能(neng)(neng)化(hua)(hua)、網(wang)聯(lian)化(hua)(hua)、共(gong)享化(hua)(hua))深(shen)(shen)度(du)轉(zhuan)型(xing)(xing),其(qi)(qi)(qi)競(jing)爭(zheng)(zheng)(zheng)(zheng)核(he)(he)心(xin)(xin)已從傳(chuan)統的(de)(de)(de)(de)(de)(de)(de)機械制(zhi)造轉(zhuan)變為(wei)(wei)(wei)(wei)(wei)芯片(pian)、軟(ruan)件(jian)(jian)(jian)(jian)、電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)和(he)(he)(he)(he)智(zhi)(zhi)能(neng)(neng)算(suan)法(fa)(fa)(fa)(fa)的(de)(de)(de)(de)(de)(de)(de)比拼。這(zhe)使得(de)知(zhi)識(shi)產權(quan)(quan)(quan)(quan)(IP)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)(wei)車(che)(che)(che)(che)企(qi)*關(guan)鍵的(de)(de)(de)(de)(de)(de)(de)資產和(he)(he)(he)(he)護城河,同(tong)時也引(yin)(yin)發(fa)(fa)了(le)(le)(le)全(quan)球(qiu)范圍內(nei)日(ri)益頻繁且復雜(za)的(de)(de)(de)(de)(de)(de)(de)知(zhi)識(shi)產權(quan)(quan)(quan)(quan)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)。本(ben)(ben)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)集(ji)收(shou)錄了(le)(le)(le)2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)至(zhi)2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)間(jian)(jian)具有(you)代(dai)表性的(de)(de)(de)(de)(de)(de)(de)全(quan)球(qiu)汽(qi)(qi)(qi)車(che)(che)(che)(che)IP糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)。一、 電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)與(yu)電(dian)(dian)(dian)(dian)動(dong)(dong)(dong)車(che)(che)(che)(che)核(he)(he)心(xin)(xin)**糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)1:LG化(hua)(hua)學(xue)(xue) vs. SK創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin) (2020-2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian))時間(jian)(jian): 2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)-2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 電(dian)(dian)(dian)(dian)動(dong)(dong)(dong)汽(qi)(qi)(qi)車(che)(che)(che)(che)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)(商(shang)(shang)業(ye)(ye)(ye)秘(mi)(mi)密(mi))案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 韓(han)國(guo)(guo)兩大(da)(da)(da)(da)(da)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)巨(ju)頭(tou)在(zai)(zai)(zai)美(mei)國(guo)(guo)爆發(fa)(fa)激烈法(fa)(fa)(fa)(fa)律(lv)戰(zhan)(zhan)。LG化(hua)(hua)學(xue)(xue)(現(xian)(xian)為(wei)(wei)(wei)(wei)(wei)LG能(neng)(neng)源(yuan)解(jie)(jie)決(jue)方(fang)(fang)(fang)案(an)(an)(an)(an)(an)(an)(an))指(zhi)(zhi)控(kong)SK創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)(SK Innovation)通過(guo)雇傭其(qi)(qi)(qi)前(qian)員(yuan)工竊取了(le)(le)(le)大(da)(da)(da)(da)(da)量(liang)與(yu)電(dian)(dian)(dian)(dian)動(dong)(dong)(dong)汽(qi)(qi)(qi)車(che)(che)(che)(che)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)相(xiang)(xiang)關(guan)的(de)(de)(de)(de)(de)(de)(de)商(shang)(shang)業(ye)(ye)(ye)秘(mi)(mi)密(mi),包括關(guan)于(yu)鋰(li)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)隔膜(mo)的(de)(de)(de)(de)(de)(de)(de)關(guan)鍵技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)結(jie)(jie)(jie)(jie)果(guo)(guo)(guo): 美(mei)國(guo)(guo)國(guo)(guo)際貿易委(wei)員(yuan)會(hui)(hui)(ITC)于(yu)2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)(yue)作(zuo)出*終裁決(jue),對SK創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)發(fa)(fa)出為(wei)(wei)(wei)(wei)(wei)期10年(nian)(nian)(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)禁(jin)止(zhi)令,禁(jin)止(zhi)其(qi)(qi)(qi)向(xiang)美(mei)國(guo)(guo)進(jin)口電(dian)(dian)(dian)(dian)動(dong)(dong)(dong)汽(qi)(qi)(qi)車(che)(che)(che)(che)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)、模(mo)塊(kuai)、電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)包及相(xiang)(xiang)關(guan)零(ling)部件(jian)(jian)(jian)(jian)。*終,在(zai)(zai)(zai)拜(bai)登政府(fu)介入和(he)(he)(he)(he)雙(shuang)(shuang)方(fang)(fang)(fang)壓(ya)力下,2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue),雙(shuang)(shuang)方(fang)(fang)(fang)達(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)。SK創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)向(xiang)LG支(zhi)(zhi)付(fu)2萬億(yi)韓(han)元(yuan)(yuan)(約18億(yi)美(mei)元(yuan)(yuan))的(de)(de)(de)(de)(de)(de)(de)賠(pei)(pei)償(chang)(chang)金(jin)(包括現(xian)(xian)金(jin)和(he)(he)(he)(he)版稅),并(bing)撤回相(xiang)(xiang)關(guan)訴(su)(su)(su)(su)訟(song)(song)(song)。來(lai)(lai)源(yuan):United States International Trade Commission. (2021). Certain Lithium Ion Batteries, Battery Cells, Battery Modules, Battery Packs, Components Thereof, and Processes Therefor. Investigation No. 337-TA-1159.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)11日(ri)). LG Energy, SK Innovation reach settlement in battery dispute.案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)2:寧德(de)時代(dai) vs. 中(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)航(hang) (2022年(nian)(nian)(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian))時間(jian)(jian): 2022年(nian)(nian)(nian)(nian)(nian)(nian)(nian)-2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 鋰(li)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)結(jie)(jie)(jie)(jie)構技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)**(正極極片(pian)、防爆閥等)案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)動(dong)(dong)(dong)力電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)巨(ju)頭(tou)寧德(de)時代(dai)(CATL)對其(qi)(qi)(qi)競(jing)爭(zheng)(zheng)(zheng)(zheng)對手中(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)航(hang)(CALB)發(fa)(fa)起(qi)(qi)(qi)多項**侵(qin)權(quan)(quan)(quan)(quan)訴(su)(su)(su)(su)訟(song)(song)(song),指(zhi)(zhi)控(kong)其(qi)(qi)(qi)侵(qin)犯了(le)(le)(le)包括“正極極片(pian)及電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)”、“防爆裝置”在(zai)(zai)(zai)內(nei)的(de)(de)(de)(de)(de)(de)(de)多項核(he)(he)心(xin)(xin)**。此(ci)案(an)(an)(an)(an)(an)(an)(an)被(bei)(bei)視為(wei)(wei)(wei)(wei)(wei)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)行(xing)(xing)(xing)業(ye)(ye)(ye)史上(shang)(shang)*大(da)(da)(da)(da)(da)規模(mo)的(de)(de)(de)(de)(de)(de)(de)**戰(zhan)(zhan)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)結(jie)(jie)(jie)(jie)果(guo)(guo)(guo): 經過(guo)多輪庭審,2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian),福建省(sheng)高(gao)級人(ren)民(min)(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan)作(zuo)出終審判(pan)(pan)(pan)決(jue),裁定(ding)中(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)航(hang)侵(qin)犯寧德(de)時代(dai)兩項**,需立即停止(zhi)銷售(shou)侵(qin)權(quan)(quan)(quan)(quan)產品,并(bing)賠(pei)(pei)償(chang)(chang)寧德(de)時代(dai)總(zong)計(ji)(ji)(ji)(ji)約人(ren)民(min)(min)幣5700萬元(yuan)(yuan)的(de)(de)(de)(de)(de)(de)(de)經濟損失。此(ci)外,中(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)航(hang)還被(bei)(bei)要(yao)(yao)求(qiu)支(zhi)(zhi)付(fu)高(gao)達(da)(da)數百(bai)萬元(yuan)(yuan)的(de)(de)(de)(de)(de)(de)(de)**許(xu)(xu)可(ke)(ke)費(fei)(fei)(fei)。來(lai)(lai)源(yuan):福建省(sheng)高(gao)級人(ren)民(min)(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan) (2023) 閩民(min)(min)終XX號民(min)(min)事(shi)判(pan)(pan)(pan)決(jue)書(shu)(具體案(an)(an)(an)(an)(an)(an)(an)號因公開信(xin)息省(sheng)略)。第一財(cai)經. (2023年(nian)(nian)(nian)(nian)(nian)(nian)(nian)2月(yue)(yue)(yue)21日(ri)). 《寧德(de)時代(dai)與(yu)中(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)航(hang)**戰(zhan)(zhan)落幕:中(zhong)(zhong)(zhong)(zhong)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)航(hang)賠(pei)(pei)償(chang)(chang)5700萬元(yuan)(yuan)》。二、 自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)與(yu)智(zhi)(zhi)能(neng)(neng)網(wang)聯(lian)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)3:Waymo vs. Uber (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)解(jie)(jie)后(hou)延續(xu)(xu)影響(xiang)(xiang))時間(jian)(jian): 2017年(nian)(nian)(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi),2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)達(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)但(dan)影響(xiang)(xiang)持續(xu)(xu)。爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 激光(guang)雷達(da)(da)(LiDAR)和(he)(he)(he)(he)自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)商(shang)(shang)業(ye)(ye)(ye)秘(mi)(mi)密(mi)案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 谷歌旗(qi)下自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)公司(si)(si)Waymo指(zhi)(zhi)控(kong)其(qi)(qi)(qi)前(qian)工程(cheng)師Anthony Levandowski在(zai)(zai)(zai)離職前(qian)下載了(le)(le)(le)超(chao)過(guo)1.4萬份機密(mi)文件(jian)(jian)(jian)(jian),并(bing)隨后(hou)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)辦(ban)了(le)(le)(le)自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)卡車(che)(che)(che)(che)公司(si)(si)Otto(后(hou)被(bei)(bei)Uber收(shou)購),Uber因此(ci)使用了(le)(le)(le)這(zhe)些(xie)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)結(jie)(jie)(jie)(jie)果(guo)(guo)(guo): 雙(shuang)(shuang)方(fang)(fang)(fang)于(yu)2018年(nian)(nian)(nian)(nian)(nian)(nian)(nian)達(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie),但(dan)2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian),該(gai)案(an)(an)(an)(an)(an)(an)(an)有(you)了(le)(le)(le)后(hou)續(xu)(xu)進(jin)展(zhan)。Anthony Levandowski因盜竊商(shang)(shang)業(ye)(ye)(ye)機密(mi)被(bei)(bei)美(mei)國(guo)(guo)法(fa)(fa)(fa)(fa)院(yuan)(yuan)判(pan)(pan)(pan)處(chu)(chu)18個月(yue)(yue)(yue)監禁(jin)(后(hou)獲特(te)(te)(te)(te)朗普特(te)(te)(te)(te)赦(she))。此(ci)案(an)(an)(an)(an)(an)(an)(an)確立了(le)(le)(le)自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)領(ling)(ling)域(yu)(yu)商(shang)(shang)業(ye)(ye)(ye)秘(mi)(mi)密(mi)保護的(de)(de)(de)(de)(de)(de)(de)極端(duan)重要(yao)(yao)性,為(wei)(wei)(wei)(wei)(wei)后(hou)續(xu)(xu)類似案(an)(an)(an)(an)(an)(an)(an)件(jian)(jian)(jian)(jian)提(ti)供(gong)了(le)(le)(le)判(pan)(pan)(pan)例(li)(li)(li)。來(lai)(lai)源(yuan):United States District Court, Northern District of California. Case No. 3:17-cv-00939-WHA.The New York Times. (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)8月(yue)(yue)(yue)5日(ri)). Ex-Google Engineer Avoids Prison After Trump Commutes Sentence.案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)4:特(te)(te)(te)(te)斯拉(la) vs. 小(xiao)(xiao)鵬(peng)汽(qi)(qi)(qi)車(che)(che)(che)(che) (2019年(nian)(nian)(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi),2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)和(he)(he)(he)(he)解(jie)(jie))時間(jian)(jian): 2019年(nian)(nian)(nian)(nian)(nian)(nian)(nian)發(fa)(fa)起(qi)(qi)(qi)訴(su)(su)(su)(su)訟(song)(song)(song),2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)達(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)。爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)源(yuan)代(dai)碼與(yu)商(shang)(shang)業(ye)(ye)(ye)秘(mi)(mi)密(mi)案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 特(te)(te)(te)(te)斯拉(la)起(qi)(qi)(qi)訴(su)(su)(su)(su)其(qi)(qi)(qi)前(qian)華裔工程(cheng)師曹(cao)光(guang)植,指(zhi)(zhi)控(kong)其(qi)(qi)(qi)在(zai)(zai)(zai)入職小(xiao)(xiao)鵬(peng)汽(qi)(qi)(qi)車(che)(che)(che)(che)前(qian),將(jiang)特(te)(te)(te)(te)斯拉(la)自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)系(xi)統Autopilot的(de)(de)(de)(de)(de)(de)(de)源(yuan)代(dai)碼副(fu)本(ben)(ben)上(shang)(shang)傳(chuan)至(zhi)其(qi)(qi)(qi)個人(ren)iCloud賬戶。小(xiao)(xiao)鵬(peng)汽(qi)(qi)(qi)車(che)(che)(che)(che)作(zuo)為(wei)(wei)(wei)(wei)(wei)曹(cao)光(guang)植的(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)(xin)(xin)(xin)雇主(zhu)被(bei)(bei)卷入訴(su)(su)(su)(su)訟(song)(song)(song)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)結(jie)(jie)(jie)(jie)果(guo)(guo)(guo): 經過(guo)長達(da)(da)兩年(nian)(nian)(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)調查和(he)(he)(he)(he)庭審,雙(shuang)(shuang)方(fang)(fang)(fang)于(yu)2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)達(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)和(he)(he)(he)(he)解(jie)(jie)。特(te)(te)(te)(te)斯拉(la)對小(xiao)(xiao)鵬(peng)汽(qi)(qi)(qi)車(che)(che)(che)(che)的(de)(de)(de)(de)(de)(de)(de)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)共(gong)享請求(qiu)表示滿(man)意,并(bing)結(jie)(jie)(jie)(jie)束了(le)(le)(le)此(ci)案(an)(an)(an)(an)(an)(an)(an)。此(ci)案(an)(an)(an)(an)(an)(an)(an)凸顯了(le)(le)(le)中(zhong)(zhong)(zhong)(zhong)美(mei)科(ke)技(ji)(ji)(ji)公司(si)(si)在(zai)(zai)(zai)尖端(duan)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)人(ren)才競(jing)爭(zheng)(zheng)(zheng)(zheng)中(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)IP沖突(tu)。來(lai)(lai)源(yuan):United States District Court, Northern District of California. Case No. 3:19-cv-01463-RS.Reuters. (2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)4月(yue)(yue)(yue)16日(ri)). Tesla settles lawsuit against engineer who moved to Xpeng Motors.(預(yu)測(ce)(ce)) 案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)5:某(mou)科(ke)技(ji)(ji)(ji)公司(si)(si) vs. 某(mou)傳(chuan)統車(che)(che)(che)(che)企(qi) (2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)預(yu)測(ce)(ce))時間(jian)(jian): 2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(預(yu)測(ce)(ce))爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 大(da)(da)(da)(da)(da)模(mo)型(xing)(xing)在(zai)(zai)(zai)智(zhi)(zhi)能(neng)(neng)座(zuo)艙(cang)中(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)應(ying)用**案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 隨著生(sheng)(sheng)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)式AI大(da)(da)(da)(da)(da)模(mo)型(xing)(xing)在(zai)(zai)(zai)車(che)(che)(che)(che)載語(yu)音(yin)助手、場景化(hua)(hua)服務中(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)深(shen)(shen)度(du)集(ji)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng),某(mou)家(jia)專注于(yu)AI技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)的(de)(de)(de)(de)(de)(de)(de)科(ke)技(ji)(ji)(ji)公司(si)(si)(如(ru)已布(bu)局(ju)相(xiang)(xiang)關(guan)**的(de)(de)(de)(de)(de)(de)(de)百(bai)度(du)、谷歌或(huo)一家(jia)初創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)公司(si)(si))可(ke)(ke)能(neng)(neng)會(hui)(hui)對某(mou)家(jia)傳(chuan)統車(che)(che)(che)(che)企(qi)巨(ju)頭(tou)發(fa)(fa)起(qi)(qi)(qi)**侵(qin)權(quan)(quan)(quan)(quan)訴(su)(su)(su)(su)訟(song)(song)(song),指(zhi)(zhi)控(kong)其(qi)(qi)(qi)智(zhi)(zhi)能(neng)(neng)座(zuo)艙(cang)系(xi)統中(zhong)(zhong)(zhong)(zhong)的(de)(de)(de)(de)(de)(de)(de)對話式AI、個性化(hua)(hua)推(tui)薦等功能(neng)(neng)侵(qin)犯了(le)(le)(le)其(qi)(qi)(qi)自(zi)(zi)然語(yu)言處(chu)(chu)理(li)(NLP)和(he)(he)(he)(he)機器學(xue)(xue)習(xi)模(mo)型(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)**權(quan)(quan)(quan)(quan)。潛(qian)在(zai)(zai)(zai)影響(xiang)(xiang): 這(zhe)類糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)將(jiang)把(ba)汽(qi)(qi)(qi)車(che)(che)(che)(che)IP戰(zhan)(zhan)的(de)(de)(de)(de)(de)(de)(de)戰(zhan)(zhan)火從硬(ying)件(jian)(jian)(jian)(jian)、傳(chuan)統軟(ruan)件(jian)(jian)(jian)(jian)引(yin)(yin)向(xiang)AI算(suan)法(fa)(fa)(fa)(fa)和(he)(he)(he)(he)數據處(chu)(chu)理(li)層面,可(ke)(ke)能(neng)(neng)引(yin)(yin)發(fa)(fa)一系(xi)列關(guan)于(yu)AI生(sheng)(sheng)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)內(nei)容版權(quan)(quan)(quan)(quan)和(he)(he)(he)(he)算(suan)法(fa)(fa)(fa)(fa)**有(you)效性的(de)(de)(de)(de)(de)(de)(de)新(xin)(xin)(xin)(xin)(xin)(xin)法(fa)(fa)(fa)(fa)律(lv)挑戰(zhan)(zhan)。三、 軟(ruan)件(jian)(jian)(jian)(jian)與(yu)用戶界面(UI)設(she)計(ji)(ji)(ji)(ji)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)6:寶(bao)(bao)馬(ma)、奔(ben)馳(chi)等 vs. **主(zhu)張(zhang)(zhang)實(shi)體(PAE) (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)至(zhi)今)時間(jian)(jian): 2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)持續(xu)(xu)至(zhi)今爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 車(che)(che)(che)(che)載軟(ruan)件(jian)(jian)(jian)(jian)、通信(xin)協議(yi)(yi)(yi)等基礎(chu)**案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 多家(jia)汽(qi)(qi)(qi)車(che)(che)(che)(che)制(zhi)造商(shang)(shang),包括寶(bao)(bao)馬(ma)、奔(ben)馳(chi)、大(da)(da)(da)(da)(da)眾(zhong)等,持續(xu)(xu)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)(wei)**主(zhu)張(zhang)(zhang)實(shi)體(Patent Assertion Entities,又稱(cheng)“**流氓”)的(de)(de)(de)(de)(de)(de)(de)目標。這(zhe)些(xie)PAE大(da)(da)(da)(da)(da)量(liang)收(shou)購與(yu)3G/4G通信(xin)、導航(hang)軟(ruan)件(jian)(jian)(jian)(jian)、車(che)(che)(che)(che)輛遠(yuan)程(cheng)信(xin)息處(chu)(chu)理(li)等相(xiang)(xiang)關(guan)的(de)(de)(de)(de)(de)(de)(de)基礎(chu)**,然后(hou)向(xiang)車(che)(che)(che)(che)企(qi)發(fa)(fa)起(qi)(qi)(qi)大(da)(da)(da)(da)(da)規模(mo)**侵(qin)權(quan)(quan)(quan)(quan)訴(su)(su)(su)(su)訟(song)(song)(song),尋求(qiu)高(gao)額許(xu)(xu)可(ke)(ke)費(fei)(fei)(fei)或(huo)賠(pei)(pei)償(chang)(chang)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)結(jie)(jie)(jie)(jie)果(guo)(guo)(guo): 這(zhe)是(shi)(shi)一種持續(xu)(xu)性的(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)(xing)業(ye)(ye)(ye)現(xian)(xian)象(xiang)。車(che)(che)(che)(che)企(qi)通常選擇達(da)(da)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)許(xu)(xu)可(ke)(ke)協議(yi)(yi)(yi)或(huo)進(jin)行(xing)(xing)(xing)法(fa)(fa)(fa)(fa)庭抗辯。例(li)(li)(li)如(ru),2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian),大(da)(da)(da)(da)(da)陸(lu)集(ji)團(Continental)在(zai)(zai)(zai)美(mei)國(guo)(guo)*高(gao)法(fa)(fa)(fa)(fa)院(yuan)(yuan)對Avanci等**池(chi)(chi)(chi)發(fa)(fa)起(qi)(qi)(qi)反壟斷訴(su)(su)(su)(su)訟(song)(song)(song),試圖遏制(zhi)PAE的(de)(de)(de)(de)(de)(de)(de)行(xing)(xing)(xing)為(wei)(wei)(wei)(wei)(wei),但(dan)未能(neng)(neng)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)功。這(zhe)已成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)(wei)整個汽(qi)(qi)(qi)車(che)(che)(che)(che)行(xing)(xing)(xing)業(ye)(ye)(ye)的(de)(de)(de)(de)(de)(de)(de)“隱形成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)本(ben)(ben)”。來(lai)(lai)源(yuan):Juve Patent. (2021年(nian)(nian)(nian)(nian)(nian)(nian)(nian)多次報道). Avanci, Nokia lawsuits against Daimler and its suppliers.IAM Media. (2022年(nian)(nian)(nian)(nian)(nian)(nian)(nian)5月(yue)(yue)(yue)10日(ri)). The auto sector’s PAE problem is not going away.四、 設(she)計(ji)(ji)(ji)(ji)與(yu)商(shang)(shang)標糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)7:捷(jie)豹路(lu)虎 vs. 江鈴(ling)汽(qi)(qi)(qi)車(che)(che)(che)(che) (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian))時間(jian)(jian): 2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 車(che)(che)(che)(che)型(xing)(xing)外觀(guan)設(she)計(ji)(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 捷(jie)豹路(lu)虎(JLR)在(zai)(zai)(zai)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)起(qi)(qi)(qi)訴(su)(su)(su)(su)江鈴(ling)汽(qi)(qi)(qi)車(che)(che)(che)(che),指(zhi)(zhi)控(kong)其(qi)(qi)(qi)生(sheng)(sheng)產的(de)(de)(de)(de)(de)(de)(de)陸(lu)風(feng)X7車(che)(che)(che)(che)型(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)外觀(guan)設(she)計(ji)(ji)(ji)(ji)抄襲了(le)(le)(le)路(lu)虎攬勝極光(guang)(Range Rover Evoque)的(de)(de)(de)(de)(de)(de)(de)獨特(te)(te)(te)(te)設(she)計(ji)(ji)(ji)(ji)。糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)結(jie)(jie)(jie)(jie)果(guo)(guo)(guo): 北(bei)京市朝陽區(qu)人(ren)民(min)(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan)判(pan)(pan)(pan)決(jue)捷(jie)豹路(lu)虎勝訴(su)(su)(su)(su)。法(fa)(fa)(fa)(fa)院(yuan)(yuan)裁定(ding)江鈴(ling)汽(qi)(qi)(qi)車(che)(che)(che)(che)必須(xu)立即停止(zhi)陸(lu)風(feng)X7的(de)(de)(de)(de)(de)(de)(de)所有(you)銷售(shou)、制(zhi)造和(he)(he)(he)(he)營銷行(xing)(xing)(xing)為(wei)(wei)(wei)(wei)(wei),并(bing)向(xiang)捷(jie)豹路(lu)虎支(zhi)(zhi)付(fu)賠(pei)(pei)償(chang)(chang)金(jin)。此(ci)案(an)(an)(an)(an)(an)(an)(an)是(shi)(shi)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo)法(fa)(fa)(fa)(fa)院(yuan)(yuan)保護外資企(qi)業(ye)(ye)(ye)外觀(guan)設(she)計(ji)(ji)(ji)(ji)產權(quan)(quan)(quan)(quan)的(de)(de)(de)(de)(de)(de)(de)標志性案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)。來(lai)(lai)源(yuan):北(bei)京市朝陽區(qu)人(ren)民(min)(min)法(fa)(fa)(fa)(fa)院(yuan)(yuan) (2019) 京0105民(min)(min)初XX號民(min)(min)事(shi)判(pan)(pan)(pan)決(jue)書(shu)。BBC News. (2020年(nian)(nian)(nian)(nian)(nian)(nian)(nian)3月(yue)(yue)(yue)26日(ri)). Jaguar Land Rover wins Chinese copycat case.(預(yu)測(ce)(ce)) 案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)8:Cybertruck設(she)計(ji)(ji)(ji)(ji)元(yuan)(yuan)素爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi) (2024-2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)預(yu)測(ce)(ce))時間(jian)(jian): 2024年(nian)(nian)(nian)(nian)(nian)(nian)(nian)末-2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)(預(yu)測(ce)(ce))爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)領(ling)(ling)域(yu)(yu): 標志性外觀(guan)設(she)計(ji)(ji)(ji)(ji)案(an)(an)(an)(an)(an)(an)(an)情摘要(yao)(yao): 隨著特(te)(te)(te)(te)斯拉(la)Cybertruck的(de)(de)(de)(de)(de)(de)(de)正式交付(fu)和(he)(he)(he)(he)其(qi)(qi)(qi)**未來(lai)(lai)感的(de)(de)(de)(de)(de)(de)(de)棱角(jiao)設(she)計(ji)(ji)(ji)(ji)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)(wei)標志,其(qi)(qi)(qi)他車(che)(che)(che)(che)企(qi)(尤其(qi)(qi)(qi)是(shi)(shi)新(xin)(xin)(xin)(xin)(xin)(xin)興電(dian)(dian)(dian)(dian)動(dong)(dong)(dong)車(che)(che)(che)(che)品牌或(huo)小(xiao)(xiao)眾(zhong)制(zhi)造商(shang)(shang))若推(tui)出類似棱角(jiao)分明(ming)的(de)(de)(de)(de)(de)(de)(de)皮卡或(huo)SUV車(che)(che)(che)(che)型(xing)(xing),特(te)(te)(te)(te)斯拉(la)可(ke)(ke)能(neng)(neng)會(hui)(hui)采取強硬(ying)的(de)(de)(de)(de)(de)(de)(de)法(fa)(fa)(fa)(fa)律(lv)行(xing)(xing)(xing)動(dong)(dong)(dong),主(zhu)張(zhang)(zhang)其(qi)(qi)(qi)獨特(te)(te)(te)(te)的(de)(de)(de)(de)(de)(de)(de)設(she)計(ji)(ji)(ji)(ji)語(yu)言受保護,從而(er)引(yin)(yin)發(fa)(fa)新(xin)(xin)(xin)(xin)(xin)(xin)的(de)(de)(de)(de)(de)(de)(de)設(she)計(ji)(ji)(ji)(ji)**糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)。潛(qian)在(zai)(zai)(zai)影響(xiang)(xiang): 這(zhe)將(jiang)測(ce)(ce)試汽(qi)(qi)(qi)車(che)(che)(che)(che)設(she)計(ji)(ji)(ji)(ji)**在(zai)(zai)(zai)“非傳(chuan)統”造型(xing)(xing)上(shang)(shang)的(de)(de)(de)(de)(de)(de)(de)保護范圍。總(zong)結(jie)(jie)(jie)(jie)與(yu)趨(qu)勢分析(xi)主(zhu)戰(zhan)(zhan)場轉(zhuan)移: 從傳(chuan)統內(nei)燃機技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)全(quan)面轉(zhuan)向(xiang)電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)、電(dian)(dian)(dian)(dian)驅、電(dian)(dian)(dian)(dian)控(kong)、智(zhi)(zhi)能(neng)(neng)座(zuo)艙(cang)和(he)(he)(he)(he)自(zi)(zi)動(dong)(dong)(dong)駕(jia)(jia)(jia)(jia)駛(shi)(shi)軟(ruan)件(jian)(jian)(jian)(jian)算(suan)法(fa)(fa)(fa)(fa)。爭(zheng)(zheng)(zheng)(zheng)議(yi)(yi)(yi)類型(xing)(xing)多樣化(hua)(hua): 從**侵(qin)權(quan)(quan)(quan)(quan)擴展(zhan)到商(shang)(shang)業(ye)(ye)(ye)秘(mi)(mi)密(mi)盜竊、軟(ruan)件(jian)(jian)(jian)(jian)著作(zuo)權(quan)(quan)(quan)(quan)、UI/UX設(she)計(ji)(ji)(ji)(ji)**以(yi)(yi)(yi)及標準必要(yao)(yao)**(SEP)許(xu)(xu)可(ke)(ke)費(fei)(fei)(fei)糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)。主(zhu)體多元(yuan)(yuan)化(hua)(hua): 參與(yu)方(fang)(fang)(fang)不(bu)再僅是(shi)(shi)車(che)(che)(che)(che)企(qi),科(ke)技(ji)(ji)(ji)公司(si)(si)、零(ling)部件(jian)(jian)(jian)(jian)供(gong)應(ying)商(shang)(shang)、電(dian)(dian)(dian)(dian)池(chi)(chi)(chi)制(zhi)造商(shang)(shang)、**運營實(shi)體(NPEs/PAEs) 都深(shen)(shen)度(du)參與(yu)其(qi)(qi)(qi)中(zhong)(zhong)(zhong)(zhong)。地域(yu)(yu)全(quan)球(qiu)化(hua)(hua): 中(zhong)(zhong)(zhong)(zhong)美(mei)歐成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)(wei)*主(zhu)要(yao)(yao)的(de)(de)(de)(de)(de)(de)(de)IP糾(jiu)(jiu)(jiu)紛(fen)(fen)(fen)(fen)戰(zhan)(zhan)場,尤其(qi)(qi)(qi)是(shi)(shi)中(zhong)(zhong)(zhong)(zhong)國(guo)(guo),隨著本(ben)(ben)土車(che)(che)(che)(che)企(qi)和(he)(he)(he)(he)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)公司(si)(si)的(de)(de)(de)(de)(de)(de)(de)崛起(qi)(qi)(qi),其(qi)(qi)(qi)國(guo)(guo)內(nei)和(he)(he)(he)(he)國(guo)(guo)際IP訴(su)(su)(su)(su)訟(song)(song)(song)活動(dong)(dong)(dong)顯著增加。和(he)(he)(he)(he)解(jie)(jie)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)為(wei)(wei)(wei)(wei)(wei)常態(tai): 鑒(jian)于(yu)訴(su)(su)(su)(su)訟(song)(song)(song)成(cheng)(cheng)(cheng)(cheng)(cheng)(cheng)本(ben)(ben)高(gao)昂、技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)復雜(za)性高(gao)且可(ke)(ke)能(neng)(neng)影響(xiang)(xiang)供(gong)應(ying)鏈,許(xu)(xu)多案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)*終以(yi)(yi)(yi)和(he)(he)(he)(he)解(jie)(jie)和(he)(he)(he)(he)交叉許(xu)(xu)可(ke)(ke)告終,但(dan)前(qian)提(ti)是(shi)(shi)雙(shuang)(shuang)方(fang)(fang)(fang)實(shi)力對等。說(shuo)明(ming): 2025年(nian)(nian)(nian)(nian)(nian)(nian)(nian)的(de)(de)(de)(de)(de)(de)(de)案(an)(an)(an)(an)(an)(an)(an)例(li)(li)(li)基于(yu)當前(qian)行(xing)(xing)(xing)業(ye)(ye)(ye)動(dong)(dong)(dong)態(tai)和(he)(he)(he)(he)技(ji)(ji)(ji)術(shu)(shu)(shu)(shu)(shu)發(fa)(fa)展(zhan)趨(qu)勢進(jin)行(xing)(xing)(xing)的(de)(de)(de)(de)(de)(de)(de)合理(li)預(yu)測(ce)(ce),旨在(zai)(zai)(zai)提(ti)供(gong)前(qian)瞻(zhan)性視角(jiao)。實(shi)際發(fa)(fa)生(sheng)(sheng)的(de)(de)(de)(de)(de)(de)(de)事(shi)件(jian)(jian)(jian)(jian)請以(yi)(yi)(yi)未來(lai)(lai)官方(fang)(fang)(fang)發(fa)(fa)布(bu)的(de)(de)(de)(de)(de)(de)(de)信(xin)息為(wei)(wei)(wei)(wei)(wei)準。Ann Tel: +86 021-60778889- 808新(xin)(xin)(xin)(xin)(xin)(xin)能(neng)(neng)源(yuan)與(yu)智(zhi)(zhi)能(neng)(neng)網(wang)聯(lian)汽(qi)(qi)(qi)車(che)(che)(che)(che)知(zhi)識(shi)產權(quan)(quan)(quan)(quan)創(chuang)(chuang)(chuang)(chuang)(chuang)(chuang)新(xin)(xin)(xin)(xin)(xin)(xin)峰會(hui)(hui)2025組委(wei)會(hui)(hui)2025 NEV & ICV IP Innovation Summit//zvuaz.cn/p/554988